Drug intelligence / Profile preview

(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a complex small molecule characterized by a 1,4-thiazane-3-carboxylic acid core, an L-Leucine moiety, and a p-toluenesulfonyl group. While specific pharmacological details for this exact molecule are not readily available, related benzothiazine derivatives have been noted for a wide range of biological and pharmacological properties, including anticancer, antioxidant, antimicrobial, antibacterial, antifungal, antiviral, antimalarial, antidiabetic, antihypertensive, anti-inflammatory, analgesic, anti-rheumatic, and anti-allergic activities. L-Leucine, a component of this compound, is an essential branched-chain amino acid crucial for protein synthesis and metabolic regulation. The p-toluenesulfonyl group is often used in organic synthesis as a protecting group or to introduce specific chemical properties. The precise mechanism of action or primary indication for this specific compound is not detailed in the provided search results, suggesting it may be a research chemical or an intermediate rather than a clinically developed drug.

02

Targets

FKBP1A

Beyond the preview

Go deeper on (3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call